Oral low-dose rapamycin treatment prevents aortic aneurysms in marfan mice

31 August 2024 (17:00 - 17:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Marcin Zaradzki

University Hospital Heidelberg, Heidelberg (Germany)

5 More presentations in this session

Presentation thumbnail

PI 3-kinase/AKT/FOXO1 signaling in smooth muscle cells protects against abdominal aortic aneurysm

Doctor M. Vantler (Cologne, DE)

Abstract Slides Video

Presentation thumbnail

Mechanosensitive Ion Channel Piezo1 regulates tight junctions between endothelium and mediates the occurrence of aortic dissection

Doctor P. Teng (Hangzhou, CN)

Abstract Slides Video

Presentation thumbnail

Comparative insights into type non-A non-B vs type B acute aortic syndromes and their blood pressure management: a monocentric, retrospective, 11-year study

Doctor F. Burgazzi (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Cardiovascular health in women with turner's syndrome: a 3-year single centre audit

Miss R. Macrae (London, GB)

Abstract Slides Video

Presentation thumbnail

Efficacy of beta blockers in patients with thoracic aortic aneurysm: meta-analysis of randomized controlled trials

Assistant Professor L. Tanriverdi (Malatya, TR)

Abstract Slides Video

Access the full session

Session thumbnail

Mechanisms of thoracic aortic disease and their treatment

The Event

Event poster

ESC Congress 2024

31 August 2024 17:00 CET

You may be interested in

Congress Presentation

Targeting mitochondrial stress with SS31 reduces ascending aortic dilation and improves cardiac performance in a preclinical model of Marfan disease.

Congress Presentation

Exploration of cyclophilin A antibody anti-eCypA as a new approach in the treatment of marfan syndrome

Congress Session

Hereditary thoracic aortic disease in the spotlight

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources